期刊文献+

脓毒症患儿中性粒细胞、淋巴细胞CD11b表达的研究 被引量:5

Study on CD11b expression of neutrophils and lymphocytes in pediatric sepsis
原文传递
导出
摘要 目的探讨脓毒症患儿中性粒细胞、淋巴细胞CD11b的表达意义。方法用流式细胞术检测脓毒症(观察组)患儿27例中性粒细胞、淋巴细胞CD11b表达,并与对照组20例和正常组20例比较。结果在急性期、恢复期,观察组中性粒细胞CD11b[(98·26±1·55)%,(97·74±1·41)%],与对照组[(86·3±6·33)%,(81·48±3·35)%]和正常组[(69·59±9·98)%]比较,P<0·05。急性期,观察组淋巴细胞CD11b[(15·17±10·2)%],低于对照组[(19·2±7·6)%],P<0·05;严重脓毒症淋巴细胞CD11b[(6·54±2·52)%]表达下调,低于脓毒症组[(19·45±8·68)%],P<0·05。结论中性粒细胞、淋巴细胞CD11b表达在脓毒症的演变过程中起到一定的作用,可作为脓毒症的判断依据,预测疾病的发展。 Objective To explore significance of CDllb expression on neutrophils and lymphocytes in pediatric sepsis. Methods Based on flow cytometry, CDllb expression on neutrophils and lymphocytes in 27 cases with pediatric sepsis, 21 cases of control group and 20 cases of normal group were measured and then compared. Results in acute and recovery period, neutrophil CDllb expression in sepsis group were [ (98.26 ±1.55) %, (97.74 ± 1.41) % ], higher than those of control group[ (86.3 ±6.33) %, (81.48 ± 3.35) % ] and normal group [ (69.59 ± 9.98) % ], P 〈 0.05 respectively. In acute period, lymphocyte CD11b expression of sepsis group was lower than that of control group [(15.17 ± 10.2)% ver (19.2 ± 7.6)%], P〈0.05. However, lymphocyte CD11b expression in severe sepsis was lower than that of sepsis [ (6.54 ± 2.52) % ver (19.45±8.68)%],P〈0.05.Conclusion CD11b expression on neutrophils and lymphocytes can affect pediatric sepsis prognosis. It can be a candidate marker of sepsis and a useful parameter for prognosis of the disease.
出处 《中国小儿急救医学》 CAS 2006年第4期331-333,共3页 Chinese Pediatric Emergency Medicine
关键词 脓毒症 CD11B 中性粒细胞 淋巴细胞 流式细胞术 Sepsis CD11b Neutrophils Lymphocytes Flow cytometry
  • 相关文献

参考文献7

二级参考文献25

  • 1武湘兵,赵克森,黄绪亮.重症烧伤大鼠白细胞粘附特性的变化[J].中华医学杂志,1994,74(5):312-314. 被引量:10
  • 2武湘兵,黄巧水,赵克森.LFA-1单克隆抗体对家兔内毒素休克微循环的影响[J].中华创伤杂志,1996,12(1):25-27. 被引量:7
  • 3Wilkinson JD, Pollack MM, Glass NL, et al. Mortality associated with multiple organ system failure and sepsis in pediatric intensive care unit. J Pediatr ,1987, 111:324-328.
  • 4Leteurtre S, Martinot A, Duhamel A, et al. Development of a pediatric multiple organ dysfunction score: use of two strategies.Medical Decision Making,1999, 19:399-410.
  • 5Leteurtre S, Martinot A, Duhamel A, et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective,observational, muhicentre study. Lancet, 2003,362 : 192-197.
  • 6Graciano AL, Balko JA, Rahn DS, et al. Development and validation of a pediatric multiple organ dysfunction score (PMODS). Crit Care Med,2001, 29(Suppl) :A176.
  • 7Goldstein B, Giroir B, Randolph A, et al. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med, 2005,6:2-8.
  • 8Carcillo JA, Fields AI. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med, 2002, 30:1365-1378.
  • 9Parker MM. Pathophysiology of cardiovascular dysfunction in septic shock. New Horiz, 1998, 6:130-138.
  • 10Bardella IJ. Pediatric advanced life support: a review of the AHA recommendations. Am Faro Phys, 1999, 60 : 1743-1750.

共引文献93

同被引文献46

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部